GW Pharma CEO after new drug launch: It's 'important to distinguish between what's medicine and what's not' in cannabis

Jim Cramer hears from GW Pharmaceuticals CEO Justin Gover about his company's cannabis-based epilepsy treatment that just launched in the United States.
08:25
Thu, Nov 1 20186:51 PM EST